"Now, the state says patients who only take these GLP-1 drugs for weight loss, are no longer covered. The governor's office has said limiting Medi-Cal coverage for GLP-1s could save the state nearly $800 million by 2029. The state is moving forward with this plan, even though the Trump administration has announced an agreement that is supposed to reduce the cost of these drugs for government insurance programs in the coming years."
"Some providers are concerned about the effect this shift will have on patients taking the drugs for obesity, who will no longer have this coverage. Dr. Wayne Ho is a Los Angeles obesity specialist. He said patients could be at risk of regaining the weight. He said there's also the physical and mental health issues that can come with that, which range from high blood pressure to depression."
TSA requires parking payments to be made online at pay.gov; travelers cannot pay TSA staff directly at the airport. California's Medi-Cal will stop covering GLP-1 drugs when prescribed solely for weight loss, a change projected to save nearly $800 million by 2029. The state is proceeding despite a federal agreement intended to lower drug costs for government programs. Providers warn patients may regain weight and face physical and mental health consequences; clinicians are shifting toward lifestyle interventions, alternative medications, and bariatric surgery, which remains covered. Medi-Cal will continue GLP-1 coverage for patients with Type 2 diabetes or cardiovascular disease. Siskiyou County agreed to a traffic-stop policy banning race-based targeting and pretextual stops.
Read at Kqed
Unable to calculate read time
Collection
[
|
...
]